Chapter 22 Fatty Acid and Triacylglycerol Metabolism

Chapter 22: Fatty Acid and Triacylglycerol Metabolism

Introduction

Birds such as the ruby-throated hummingbird store energy efficiently through fats, necessary for their high-energy lifestyle. Fatty acids are highly reduced, meaning they carry more electrons per carbon, and are stored in an anhydrous form, making them a very compact and energy-dense fuel source.
The bird beats its wings approximately $50$ times per second, utilizing energy from stored fat to fly across the Gulf of Mexico for several hours, a feat requiring immense and sustained energy output.
The processes of fatty acid synthesis (for energy storage) and degradation (for energy use) are essentially reverse processes; however, they occur in different cellular compartments, utilize different cofactors, and involve distinct enzyme systems to ensure independent regulation and prevent futile cycles.

Learning Goals

By the end of this chapter, you should be able to:

Identify the repeated steps of fatty acid degradation.
Describe ketone bodies and their role in metabolism.
Explain how fatty acids are synthesized.
Explain how fatty acid metabolism is regulated.

Outline

22.1 Triacylglycerols Are Highly Concentrated Energy Stores
22.2 The Use of Fatty Acids as Fuel Requires Three Stages of Processing
22.3 Unsaturated and Odd-Chain Fatty Acids Require Additional Steps for Degradation
22.4 Ketone Bodies Are a Fuel Source Derived from Fats
22.5 Fatty Acids Are Synthesized by Fatty Acid Synthase
22.6 The Elongation and Unsaturation of Fatty Acids Are Accomplished by Accessory Enzyme Systems
22.7 Acetyl CoA Carboxylase Plays a Key Role in Controlling Fatty Acid Metabolism

Section 22.1: Triacylglycerols Are Highly Concentrated Energy Stores

Triacylglycerols: also known as neutral fats or triglycerides, are uncharged esters of three fatty acids with a single glycerol molecule. Their hydrophobic and uncharged nature allows them to pack tightly within cells, maximizing energy storage in minimal space.
Main storage site is in adipose tissue; muscles also store triacylglycerols for immediate energy needs during sustained activity.
Triacylglycerols provide a highly concentrated source of energy due to their highly reduced state and anhydrous nature.
- Complete oxidation of fatty acids yields approximately $38 \text{ kJ g}^{-1}$ compared to $17 \text{ kJ g}^{-1}$ for carbohydrates and proteins. This nearly $2.25$ -fold difference is due to fats being more reduced (containing more C-H bonds) and requiring less water for storage.
- A gram of nearly anhydrous fat stores $6.75$ times more energy than a gram of hydrated glycogen, highlighting their efficiency for long-term energy reserves and light-weight energy storage in migratory animals.

Adipose Tissue and Adipocytes

Adipose tissue: a fuel-rich, white tissue located under the skin (subcutaneous fat) and surrounding internal organs (visceral fat), serving as the body's primary energy reservoir.
Adipocytes: specialized fat cells that comprise adipose tissue, serving as the primary site for triacylglycerol accumulation and metabolism.
- Each adipocyte contains a large, single lipid droplet which may occupy most of the adipocyte's volume, surrounded by a phospholipid monolayer and proteins like perilipins, vital for lipid metabolism and for regulating access by lipases.

Dietary Lipids Are Digested by Pancreatic Lipases

Lipases: intestinal enzymes, primarily secreted by the pancreas into the small intestine, responsible for degrading triacylglycerols into free fatty acids and 2-monoacylglycerol, making them available for absorption.

Bile Acids and Colipase

Lipids exit the stomach as coarse emulsions. In the small intestine, these are further emulsified into finer droplets by bile acids, increasing their surface area for enzyme action.
- Bile acids: amphipathic molecules synthesized from cholesterol in the liver and secreted into the small intestine. They act as biological detergents, breaking down large lipid droplets into smaller micelles, thus increasing the surface area for lipase action.
- Colipase: a small protein that binds to both the pancreatic lipase and the lipid-water interface of the micelle. It enhances the enzyme's access to the ester bonds of triacylglycerols, overcoming the inhibitory effect of bile acids at the micelle surface.
- Bile acids physically orient the ester bonds of triacylglycerols to make them accessible to pancreatic lipases.

Chylomicron Formation and Degradation

Chylomicrons: large lipoprotein particles formed in intestinal epithelial cells (enterocytes), composed of newly synthesized triacylglycerols, proteins (apolipoproteins), phospholipids, and cholesterol. They are released into the lymph and then the bloodstream to efficiently transport dietary lipids to various peripheral tissues.
Once in the capillaries of adipose tissue and muscles, chylomicrons are degraded by lipoprotein lipase (LPL), an enzyme anchored to the endothelial cells. LPL hydrolyzes triacylglycerols within the chylomicrons into free fatty acids and glycerol, which are then absorbed by the local cells.

Fat Absorption and Transport

Free fatty acids and monoacylglycerols are absorbed by intestinal epithelial cells (enterocytes) from the lumen of the small intestine via specific protein transporters.
Inside the enterocytes, triacylglycerols are reconstructed in the smooth endoplasmic reticulum (SER) from the absorbed fatty acids and 2-monoacylglycerol.
These triacylglycerols, along with other lipids and apolipoproteins, are then packaged into chylomicrons. Chylomicrons are subsequently released into the lymphatic system and eventually enter the blood for distribution to tissues throughout the body.

Section 22.2: The Use of Fatty Acids as Fuel Requires Three Stages of Processing

Mobilization: Lipids are freed through a carefully regulated process of triacylglycerol degradation, released from adipose tissue, and transported via the bloodstream to energy-requiring tissues like muscle, heart, or liver, especially during periods of fasting or increased energy demand.
Activation and Transport: Fatty acids are first activated by linkage to coenzyme A in the cytosol and then transported into the mitochondrial matrix, the primary site where $\beta$ -oxidation occurs.
Breakdown: Fatty acids undergo a stepwise degradation process called $\beta$ -oxidation to yield acetyl CoA. This acetyl CoA then enters the citric acid cycle for further oxidation and ATP generation via oxidative phosphorylation.

Mobilization: Triacylglycerols Are Hydrolyzed by Hormone-Stimulated Lipases

Hormonal control of lipases catalyzes the hydrolysis of triacylglycerols into fatty acids and glycerol. This process is primarily triggered by hormones like glucagon (indicating low blood glucose) and epinephrine (indicating stress or energy demand).
These hormones bind to specific G protein-coupled receptors on adipocytes, initiating a signal transduction cascade:
- Binding activates adenylyl cyclase, leading to an increase in intracellular cyclic AMP (cAMP) levels.
- Elevated cAMP activates protein kinase A (PKA), which then phosphorylates two key proteins:
  - Perilipin: a fat-droplet-associated protein that, when phosphorylated, undergoes a conformational change. This change promotes the release of adipose triglyceride lipase (ATGL) from perilipin and enables it to bind to the lipid droplet and initiate the hydrolysis of triacylglycerols to diacylglycerols.
  - Hormone-sensitive lipase (HSL): PKA phosphorylation activates HSL, which then primarily breaks down diacylglycerol into free fatty acid and monoacylglycerol.
Monoacylglycerol lipase (MGL): further breaks down monoacylglycerol into free fatty acid and glycerol, completing the mobilization of stored fat.

Triacylglycerols in Adipose Tissue Converted to Free Fatty Acids

The entire process of triacylglycerol breakdown in adipocytes is hormonally regulated, stimulated by multiple steps involving PKA phosphorylation of perilipin, activation of ATGL (which primarily acts on triacylglycerols), and subsequent enzymatic actions of HSL (acting on diacylglycerols) and MGL (acting on monoacylglycerols), leading to the complete mobilization of fatty acids.

The Liver and Lipid Metabolism

Hepatocytes (liver cells) play a major role in lipid processing, highly responsive to dietary intake and systemic energy needs. They can synthesize, degrade, and modify fatty acids, and also form ketone bodies during fasting.
The epinephrine/cAMP pathway that regulates lipolysis may be disrupted by ethanol. Chronic ethanol consumption can alter the mitochondrial NADH/ $\text{NAD}^+$ ratio, favoring fatty acid synthesis over oxidation, leading to the accumulation of triacylglycerols in the liver (alcoholic fatty liver disease).

Mobilization Continues

Albumin: Once released from adipocytes, free fatty acids are insoluble in blood plasma. They are transported in the bloodstream by albumin, a large serum protein that has multiple hydrophobic binding sites for fatty acids, allowing their efficient and safe delivery to peripheral tissues.
Glycerol released from triacylglycerol hydrolysis is transported to the liver, where it is phosphorylated to glycerol 3-phosphate by glycerol kinase. Glycerol 3-phosphate can then be oxidized to dihydroxyacetone phosphate (DHAP), an intermediate of glycolysis and gluconeogenesis, depending on the metabolic needs of the cell.

Activation: Fatty Acids Linked to Coenzyme A

Fatty acids enter intestinal cells and other peripheral tissues via specific transport proteins. To be metabolized, they must first be activated.
Acyl CoA synthetase (also known as fatty acyl CoA ligase): catalyzes the linkage of fatty acids to coenzyme A, forming a high-energy thioester linkage (acyl CoA). This activation step occurs on the outer mitochondrial membrane (and ER membrane) and requires the hydrolysis of ATP to AMP and PPi, effectively committing the fatty acid to catabolism.

Acyl CoA Synthetase Activates Fatty Acid in Two Steps

Formation of acyl adenylate (fatty acyl AMP) and pyrophosphate (PPi) from fatty acid and ATP. The fatty acid carboxylate attacks the $\alpha$ -phosphate of ATP, displacing PPi.
Transfer of CoA to the acyl adenylate, yielding acyl CoA and AMP. The sulfhydryl group of CoA-SH attacks the acyl adenylate, releasing AMP.

The Overall Reaction of Acyl CoA Synthetase

The net reaction is:
$\text{RCOO}^- + \text{CoA} + \text{ATP} + \text{H}_2\text{O} \ \ \rightarrow \text{RCO-CoA} + \text{AMP} + 2 \text{Pi} + 2 \text{H}^+$
The subsequent and rapid hydrolysis of PPi into two inorganic phosphates (2 Pi) by inorganic pyrophosphatase makes the overall activation reaction highly exergonic and irreversible, ensuring that fatty acid activation proceeds effectively in the mitochondrial membrane.

Transport: Carnitine and Fatty Acid Entry to Mitochondria

Carnitine: a small, amino acid-derived molecule that carries long-chain fatty acids (as acyl carnitines) across the impermeable inner mitochondrial membrane into the mitochondrial matrix, where $\beta$ -oxidation takes place. Short-chain fatty acids ( \text{< 12 carbons} ) can cross the inner mitochondrial membrane directly without carnitine assistance.

Acyl Carnitine Translocase

Carnitine acyltransferase I (CATI) (also known as CPT I): located on the outer mitochondrial membrane, it transfers the acyl group from acyl CoA to carnitine, forming acyl carnitine and releasing free CoA.
Acyl carnitine translocase: an antiporter protein embedded in the inner mitochondrial membrane, which exchanges one acyl carnitine molecule from the intermembrane space for one free carnitine molecule from the mitochondrial matrix, effectively moving acyl carnitine into the matrix.
Carnitine acyltransferase II (CATII) (also known as CPT II): located on the inner face of the inner mitochondrial membrane, it transfers the acyl group from acyl carnitine back to coenzyme A, regenerating acyl CoA within the mitochondrial matrix and releasing free carnitine, which then returns to the intermembrane space via the translocase.

Breakdown: Producing Acetyl CoA from Fatty Acids

The $\beta$ -oxidation pathway, occurring in the mitochondrial matrix, encompasses four repeated steps that systematically shorten the fatty acyl CoA chain by two carbons in each cycle:

Oxidation by FAD: Acyl CoA is oxidized by acyl CoA dehydrogenase (creating a $trans-\Delta2$ -enoyl CoA), producing $\text{FADH}_2$ from FAD.
Hydration: The double bond of $trans-\Delta2$ -enoyl CoA is hydrated by enoyl CoA hydratase, forming L-3-hydroxyacyl CoA.
Oxidation by NAD $^+$ : The L-3-hydroxyacyl CoA is oxidized by L-3-hydroxyacyl CoA dehydrogenase, producing $\text{NADH} + \text{H}^+$ from $\text{NAD}^+$ and forming $\beta$ -ketoacyl CoA.
Thiolysis by coenzyme A: The $\beta$ -ketoacyl CoA is cleaved by $\beta$ -ketothiolase (thiolase) through the addition of a molecule of CoA-SH, releasing one molecule of acetyl CoA and a new acyl CoA that is two carbons shorter than the original.

This cycle continues until the fatty acid chain is completely converted to acetyl CoA units.

Different Length Fatty Acid Chains Require Different Enzymes

Various dehydrogenases act on different length chains due to distinct substrate specificities:
- Very long-chain acyl CoA dehydrogenase: acts on fatty acids with $20$ carbons or more.
- Long-chain acyl CoA dehydrogenase: 12-18 carbons.
- Medium-chain acyl CoA dehydrogenase: 4-14 carbons.
- Short-chain acyl CoA dehydrogenase: 4-6 carbons.
- Other enzymes like enoyl CoA hydratase and $\beta$ -ketothiolase typically act on a broader range of fatty acid lengths.

Each Round of Fatty Acid Degradation Removes Two Carbons

Key steps of the $\beta$ -oxidation cycle provide detailed insight into the biochemical changes during fatty acid degradation, which consistently produces $1$ $\text{FADH}_2$ , $1$ $\text{NADH}$ , and $1$ acetyl CoA per cycle (except for the last cycle of an even-chain fatty acid, which produces $2$ acetyl CoA).

The Complete Oxidation of Palmitate Yields 106 Molecules of ATP

Palmitate ( $\text{C}_{16}$ ), a common saturated fatty acid, undergoes $7$ rounds of $\beta$ -oxidation to yield $8$ molecules of acetyl CoA.
The overall reaction for palmitoyl CoA is:
$\text{Palmitoyl CoA} + 7 \text{ FAD} + 7 \text{ NAD}^+ + 7 \text{ CoA} + 7 \text{ H}2\text{O} \rightarrow 8 \text{ acetyl CoA} + 7 \text{ FADH}2 + 7 \text{ NADH} + 7 \text{ H}^+$
ATP yield calculation for palmitate:
- Activation of palmitate to palmitoyl CoA costs $2$ ATP equivalents (ATP (\rightarrow) AMP).
- $7 \text{ FADH}2$ generated in $\beta$ -oxidation: $7 \times 1.5 \text{ ATP/FADH}2 = 10.5 \text{ ATP}$ .
- $7 \text{ NADH}$ generated in $\beta$ -oxidation: $7 \times 2.5 \text{ ATP/NADH} = 17.5 \text{ ATP}$ .
- $8$ acetyl CoA molecules enter the citric acid cycle: $8 \times 10 \text{ ATP/acetyl CoA} = 80 \text{ ATP}$ .
- Total ATP: $10.5 + 17.5 + 80 = 108 \text{ ATP}$ . Factoring in the initial activation cost, the net yield is $108 - 2 = 106 \text{ ATP}$ , highlighting the immense energy density of fats.

Section 22.3: Unsaturated and Odd-Chain Fatty Acids Require Additional Steps for Degradation

$\beta$ -oxidation cannot exclusively degrade unsaturated fatty acids directly due to the presence of $cis$ double bonds and their position relative to the carbonyl group, which are incompatible with the enzymes of the standard pathway.
Degradation of monounsaturated fatty acids like oleate ( $\text{C}_{18}:1\Delta^9$ ) results in the formation of $cis-\Delta3$ -enoyl CoA after a few rounds of $\beta$ -oxidation. This intermediate is not a substrate for enoyl CoA hydratase and requires enoyl CoA isomerase to convert it to $trans-\Delta2$ -enoyl CoA, a suitable substrate for continued $\beta$ -oxidation.
Polyunsaturated fatty acids, such as linoleate, require an additional enzyme, 2,4-dienoyl CoA reductase, in conjunction with the isomerase, to correctly position and reduce multiple double bonds for further $\beta$ -oxidation.
Odd-chain fatty acids: The $\beta$ -oxidation of fatty acids with an odd number of carbons proceeds normally until the final cycle, which yields one acetyl CoA and one propionyl CoA ( $\text{C}_3$ ).
Propionyl CoA is then converted to succinyl CoA (a citric acid cycle intermediate) via a three-step pathway mainly in the liver:
1. Propionyl CoA carboxylase (biotin-dependent) converts propionyl CoA to D-methylmalonyl CoA, consuming ATP and $\text{HCO}_3^-$ .
2. Methylmalonyl CoA epimerase converts D-methylmalonyl CoA to L-methylmalonyl CoA.
3. Methylmalonyl CoA mutase (vitamin $\text{B}_{12}$ -dependent) converts L-methylmalonyl CoA to succinyl CoA, which can then enter the citric acid cycle to be further oxidized or contribute to gluconeogenesis.

Fatty Acids are Also Oxidized in Peroxisomes

Peroxisomes: organelles primarily involved in the initial oxidation of very long-chain fatty acids (VLCFA, typically \text{>20 carbons} ), branched-chain fatty acids (e.g., phytanic acid), or dicarboxylic fatty acids, which are too long or structured to be directly handled by mitochondrial $\beta$ -oxidation.
Peroxisomal $\beta$ -oxidation shares similarities with mitochondrial processes but has key differences:
- The first oxidation step is catalyzed by acyl CoA oxidase, which forms a $trans-\Delta2$ -enoyl CoA and produces hydrogen peroxide ( $\text{H}2\text{O}2$ ) instead of $\text{FADH}_2$ . The energy from this step is released as heat, not conserved as ATP.
- $\text{H}2\text{O}2$ is then rapidly degraded by catalase within the peroxisome to prevent cellular damage.
Once shortened to a length suitable for mitochondria (e.g., medium-chain fatty acids), the partially degraded fatty acids are transported to the mitochondria for complete oxidation.

Pathologic Conditions Related to Dietary Fatty Acids

High intake of saturated fats and trans fats is linked to negative health outcomes, such as obesity, insulin resistance, and type 2 diabetes. The mechanisms include lipotoxicity, where excessive fatty acids accumulate in non-adipose tissues, impairing mitochondrial function, inhibiting $\beta$ -oxidation, and inducing endoplasmic reticulum stress, which ultimately disrupts insulin signaling pathways.

Section 22.4: Ketone Bodies Are a Fuel Source Derived from Fats

Under conditions of prolonged fasting, starvation, or uncontrolled diabetes, glucose availability is low, and the liver extensively mobilizes and oxidizes fatty acids. This leads to an overproduction of acetyl CoA in the liver, which exceeds the capacity of the citric acid cycle (due to low oxaloacetate levels diverted for gluconeogenesis).
In such states, acetyl CoA is diverted from the citric acid cycle to form ketone bodies in the mitochondrial matrix of liver cells.
Ketone bodies include acetoacetate, D-3-hydroxybutyrate, and acetone; they serve as a transportable and water-soluble energy source for peripheral tissues, particularly the heart, renal cortex, and brain (which gradually adapts to using them during prolonged starvation).

Ketone Body Formation in the Liver

Key liver enzymes produce ketone bodies:
1. Two molecules of acetyl CoA condense to form acetoacetyl CoA, catalyzed by thiolase (the reverse of the last step of $\beta$ -oxidation).
2. Acetoacetyl CoA combines with another acetyl CoA to form HMG-CoA, catalyzed by HMG-CoA synthase.
3. HMG-CoA is cleaved by HMG-CoA lyase to yield acetoacetate and acetyl CoA.
Acetoacetate is a primary product that can spontaneously decarboxylate to form acetone (a volatile compound responsible for the fruity breath odor characteristic of diabetic ketoacidosis) or be reduced to D-3-hydroxybutyrate by D-3-hydroxybutyrate dehydrogenase.
The ratio of D-3-hydroxybutyrate to acetoacetate in the blood is dictated by the mitochondrial $\text{NADH/NAD}^+$ ratio: a higher $\text{NADH/NAD}^+$ ratio favors the formation of D-3-hydroxybutyrate.

Use of Ketone Bodies as Fuel

Ketone bodies are transported from the liver (which cannot use them due to the absence of the enzyme CoA transferase) to tissues like the heart, skeletal muscle, and brain.
In these peripheral tissues, D-3-hydroxybutyrate is first oxidized back to acetoacetate (producing NADH). Acetoacetate is then activated by transfer of CoA from succinyl CoA (catalyzed by CoA transferase, also known as 3-oxoacid CoA transferase) to form acetoacetyl CoA. Finally, acetoacetyl CoA is cleaved by thiolase into two molecules of acetyl CoA, which can then enter the citric acid cycle to generate ATP.

Ketogenic Diets and Their Clinical Application

Ketogenic diets: high-fat, very low-carbohydrate, and adequate-protein diets that induce a metabolic state similar to fasting, promoting the production and utilization of ketone bodies.
They have significant therapeutic potential, particularly for drug-resistant epilepsy in children, where they can reduce seizure frequency and severity. Proposed mechanisms include altered neurotransmitter synthesis, enhanced mitochondrial function, and changes in gene expression.
Research indicates potential benefits beyond epilepsy, such as lifespan extension and cognitive enhancement, possibly related to changes in gut microbiome composition and metabolic signaling pathways.

Diabetic Ketoacidosis as a Pathological Condition

Diabetic ketoacidosis (DKA) is a life-threatening complication of uncontrolled type 1 diabetes (and sometimes type 2). The absolute or relative lack of insulin in diabetes leads to:
- Impaired glucose uptake by cells, mimicking starvation.
- Unchecked glucagon and epinephrine secretion, leading to rampant fatty acid mobilization from adipose tissue.
- Massive production of acetyl CoA in the liver, exceeding TCA cycle capacity, causing excessive ketone body synthesis.
- The accumulation of strong organic acids (acetoacetate and D-3-hydroxybutyrate) significantly lowers blood pH (acidosis), leading to metabolic dysregulation, dehydration, and electrolyte imbalances that can be fatal if untreated.

Animals Cannot Convert Fatty Acids into Glucose

Acetyl CoA derived from fatty acids cannot undergo a net conversion back to glucose in animals. This is because the two carbons of acetyl CoA that enter the citric acid cycle are ultimately released as two molecules of $\text{CO}_2$ . There is no pathway in animals to convert acetyl CoA into pyruvate or oxaloacetate (key gluconeogenic precursors) in a net sense.
Plants and some microorganisms, however, possess the glyoxylate cycle, which allows for the net conversion of fatty acids to carbohydrates.

Section 22.5: Fatty Acids Are Synthesized by Fatty Acid Synthase

Fatty acid synthase: a multi-enzyme complex in animals (a single polypeptide chain with multiple catalytic domains), responsible for the de novo synthesis of saturated long-chain fatty acids, primarily palmitate ( $\text{C}_{16}$ ), from acetyl CoA. This complex process occurs in the cytosol.

Fatty Acid Synthesis and Degradation Contrast in Mechanism

Fatty acid synthesis:
- Occurs in the cytosol.
- Is a reductive process, requiring NADPH as the electron donor (primarily supplied by the pentose phosphate pathway and malic enzyme).
- Builds fatty acids by adding two-carbon units from malonyl CoA.
- Uses an acyl carrier protein (ACP) to hold growing fatty acyl intermediates, acting as a flexible arm.
Fatty acid degradation ( $\beta$ -oxidation):
- Occurs in the mitochondrial matrix.
- Is an oxidative process, producing NADH and FADH $_2$ .
- Breaks down fatty acids by removing two-carbon units as acetyl CoA.
- Uses Coenzyme A (CoA) to carry fatty acyl intermediates.

Forming Malonyl CoA: The Committed Step

Acetyl CoA carboxylase (ACC): catalyzes the first committed and rate-limiting step of fatty acid synthesis. This enzyme converts acetyl CoA to malonyl CoA by adding a bicarbonate molecule, consuming ATP. It crucially requires biotin as a prosthetic group, which covalently carries the activated $\text{CO}_2$ .
The formation of malonyl CoA integrates critical metabolic pathways and regulatory mechanisms, controlling the flux towards fatty acid synthesis and away from $\beta$ -oxidation.

Regulation of Fatty Acid Metabolism

Acetyl CoA carboxylase (ACC) is the primary point of regulation for fatty acid synthesis and is exquisitely regulated by cellular conditions and various hormones.
Allosteric regulation:
- ACC is allosterically activated by citrate (indicating abundant energy and carbon precursors available for storage).
- Conversely, it is allosterically inhibited by palmitoyl CoA (a long-chain fatty acyl CoA, signaling sufficient fatty acid levels and a need to cease synthesis).
Hormonal regulation (covalent modification):
- Insulin (high glucose levels) activates ACC by promoting its dephosphorylation, leading to increased fatty acid synthesis to store excess energy.
- Glucagon and epinephrine (low glucose/stress conditions) inhibit ACC by promoting its phosphorylation (via PKA), reducing fatty acid synthesis and favoring fatty acid oxidation to release energy.

Adaptive Control of Enzyme Regulation

Enzyme levels related to fatty acid metabolism adapt based on long-term dietary conditions. For instance, a high-carbohydrate, low-fat diet will induce the synthesis of ACC and fatty acid synthase over time, indicating a complex regulatory system responding to energy availability and needs at the genetic level to maintain metabolic homeostasis.

Conclusion

Fatty acid metabolism presents intricate biochemical cycles crucial for maintaining cellular and organismal energy balance. This highlights the profound significance of precise enzymatic control and hormonal signaling in regulating these anabolic (synthesis) and catabolic (degradation) pathways, ensuring the efficient storage and utilization of energy resources.